Deploying a new machine learning model to production is one of the most critical stages of the ML lifecycle. Even if a model performs well on validation and test datasets, directly replacing the ...

In December, Howard Marks published an investment memo titled, “Is it a bubble?” that expressed some of his skepticism and reservations about artificial intelligence and the stock-market boom it had ...

Sauce Labs Inc., a continuous testing solutions provider, today announced the general availability of its Real Device Access API, changing how the company delivers mobile testing infrastructure and ...

Try the demo mode to see how it works, or connect a backend to run actual k6 tests. See web/ for local development or WEB_DEPLOYMENT.md for deployment instructions.

Learn how to build and test narrowboat steps with this companionway tutorial, covering precise measurements, secure installation, and safety checks. Perfect for DIY narrowboat owners aiming to improve ...

In this tutorial, we show how we treat prompts as first-class, versioned artifacts and apply rigorous regression testing to large language model behavior using MLflow. We design an evaluation pipeline ...

Spotify is changing how its APIs work in Developer Mode, its layer that lets developers test their third-party applications using the audio platform’s APIs. The changes include a mandatory premium ...

Abstract: Large Language Models have emerged as the top-notch tool in the software engineering field, from requirement gathering and analysis to code generation. Several approaches have been developed ...

OpenAI announced it will begin testing ads within ChatGPT in the coming weeks. Ads will begin to appear at the bottom of the chatbot's answers, and they will be clearly labeled, OpenAI said. OpenAI ...

The Italian startup will use the investment to build proprietary AI models, accelerate global expansion, and hire new talent. Italian cybersecurity startup Equixly on Tuesday announced raising €10 ...

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...